Lightning Round: Pfizer, Green Mountain Coffee, Motorola and More

Omnivision Technologies : Cramer is bullish on OTVI, as its tech is in Apple’s iPad, but he recommended waiting for a pullback before buying.

Pfizer : “Pfizer is my least favorite drug stock,” Cramer said. Too many of the company’s drugs are set to come off patent, and that will hurt earnings.

KKR Financial : “It’s a winner,” Cramer said. “I think you continue to buy it.”

Green Mountain Coffee Roasters : “I am not a fan,” Cramer said. Sell GMCR.

Motorola : If Carl Icahn is willing to bank with this company, Cramer said investor may want to as well. MOT is a buy.

When this story published, Cramer's charitable trust owned Apple.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book